Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein

Clinical trial NCT03071224 · COMPLETED

Trial details

NCT number: NCT03071224
Sponsor: Invicro
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Healthy Volunteers

Start date: 2016-06-01
Primary completion: 2021-06-09
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.